Prognostic significance of the dna-index in liver transplantation for hepatocellular carcinoma in cirrhosis

Annals of Surgery

Volumn 250, Issue 6, 2009, Pages 1008-1013

  Jonas, Sven ^a,b   Al Abadi, Houssein ^a   Benckert, Christoph ^a,b   Thelen, Armin ^a,b   Hippler Benscheid, M ^a   Saribeyoglu, Kaya ^a   Radtke, Birgit ^a   Pratschke, Johann ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DNA; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; DNA INDEX; FEMALE; FEULGEN STAINING; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE CYTOMETRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

AGED; CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 73449138381     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b2b195     Document Type: Article

References (34)

1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699.
2. Llovet JM, Bruix J, Fuster J, et al. Liver transplantation for small hepatocel-lular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology. 1998;27:1572-1577.
3. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and his-topathologic grading determine outcome after liver transplantation for hepa-tocellular carcinoma in cirrhosis. Hepatology. 2001;33:1080-1086.
4. Capussotti L, Ferrero A, Viganò L, et al. Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines. Eur J Surg Oncol. 2009;35:11-15.
5. Llovet JM, Schwartz M, Fuster J, et al. Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there. Semin Liver Dis. 2006;26:248-253.
6. Fung J, Marsh W. The quandary over liver transplantation for hepatocellular carcinoma: the greater sin? Liver Transpl. 2002;8:775-777.
7. Marsh JW, Finkelstein SD, Demetris AJ, et al. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival. Liver Transpl. 2003;9:664-671.
8. Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer. 2005;5:773-785.
9. Schulte EKW, Seigneuring D, Giroud F, et al. DNA densitometry. In: Hamilton PW, Allen DC, eds. Quantitative Clinical Pathology. Oxford: Blackwell Science; 1995:140-169.
10. Haroske G, Dimmer V, Meyer W, et al. DNA histogram interpretation based on statistical approaches. Anal Cell Pathol. 1997;15:157-173.
11. Chieco P, Jonker A, Melchiorri C, et al. A user's guide for avoiding errors in absorbance image cytometry: a review with original experimental observations. Histochem J. 1994;26:1-19.
12. Ishizu H. Flow cytometric analysis of the nuclear DNA content of hepato-cellular carcinoma. Jpn J Surg. 1989;19:662-673.
13. Fujimoto J, Okamoto E, Yamanaka N, et al. Flow cytometric DNA analysis of hepatocellular carcinoma. Cancer. 1991;67:939-944.
14. McEntee GP, Batts KA, Katzmann JA, et al. Relationship of nuclear DNA content to clinical and pathologic findings in patients with primary hepatic malignancy. Surgery. 1992;111:376-379.
15. Ezaki T, Kanematsu T, Okamura T, et al. DNA analysis of hepatocellular carcinoma and clinicopathologic implications. Cancer. 1988;61:106-109.
16. Okada S, Ishii H, Nose H, et al. Intratumoral DNA heterogeneity of small hepatocellular carcinoma. Cancer. 1995;75:444-450.
17. Zeng WJ, Liu GY, Xu J, et al. Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma. World J Gastroenterol. 2002;8:1040-1044. (Pubitemid 35446417)
18. Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200-207.
19. Vauthey JN, Lauwers GY. Prognostic factors after resection of hepatocellular carcinoma: are there landmarks in the wild forest? J Hepatol. 2003;38:237-239.
20. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33:1394-1403.
21. Jonas S, Mittler J, Pascher A, et al. Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center. Liver Transpl. 2007;13:896-903.
22. Delgado R, Mikuz G, Hofstädter F. DNA-Feulgen-cytophotometric analysis of single cells isolated from paraffin embedded tissue. Pathol Res Pract. 1984;179:92-94.
23. Hedley DW, Friedlander ML, Taylor IW. Application of DNA flow cytom-etry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry. 1985;6:327-333.
24. Haroske G, Giroud F, Reith A, et al. 1997 ESACP consensus report on diagnostic DNA image cytometry. Part I: basic considerations and recommendations for preparation, measurement and interpretation. European Society for Analytical Cellular Pathology. Anal Cell Pathol. 1998;17:189-200.
25. Hiddemann W, Schumann J, Andreef M, et al. Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology. Cancer Genet Cytogenet. 1984;13:181-183.
26. Sing T, Sander O, Beerenwinkel N, et al. ROCR: visualizing classifier performance in R. Bioinformatics. 2005;21:3940-3941.
27. Jonas S, Neuhaus R, Junge G, et al. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up. Int Immunopharmacol. 2005;5: 125-128.
28. Wilkens L, Flemming P, Gebel M, et al. Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma. Proc Natl Acad Sci USA. 2004;101:1309-1314.
29. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature. 1997;386:623-627.
30. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396:643-649.
31. Mas VR, Fisher RA, Archer KJ, et al. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results. Transplantation. 2007; 83:973-981.
32. Mas VR, Maluf DG, Archer KJ, et al. Differentially expressed genes between early and advanced hepatocellular carcinoma (HCC) as a potential tool for selecting liver transplant recipients. Mol Med. 2006;12:97-104.
33. Tsunedomi R, Iizuka N, Yamada-Okabe H, et al. Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile. Int J Oncol. 2006;29:1445-1451.
34. Thorgeirsson SS, Lee JS, Grisham JW. Molecular prognostication of liver cancer: end of the beginning. J Hepatol. 2006;44:798-805.